Columbus Circle Investors raised its stake in shares of Humana Inc. (NYSE:HUM) by 1,259.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 185,236 shares of the insurance provider’s stock after buying an additional 171,613 shares during the period. Columbus Circle Investors owned approximately 0.13% of Humana worth $44,571,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. State Board of Administration of Florida Retirement System increased its stake in Humana by 2.0% in the second quarter. State Board of Administration of Florida Retirement System now owns 223,001 shares of the insurance provider’s stock valued at $53,659,000 after buying an additional 4,399 shares during the period. Financial Advisors Network Inc. increased its stake in shares of Humana by 3.4% in the second quarter. Financial Advisors Network Inc. now owns 1,413 shares of the insurance provider’s stock worth $340,000 after buying an additional 46 shares during the last quarter. BB&T Securities LLC increased its stake in shares of Humana by 43.9% in the second quarter. BB&T Securities LLC now owns 2,520 shares of the insurance provider’s stock worth $606,000 after buying an additional 769 shares during the last quarter. KBC Group NV increased its stake in shares of Humana by 66.7% in the second quarter. KBC Group NV now owns 93,817 shares of the insurance provider’s stock worth $22,575,000 after buying an additional 37,538 shares during the last quarter. Finally, Ballentine Partners LLC increased its stake in shares of Humana by 15.9% in the second quarter. Ballentine Partners LLC now owns 1,400 shares of the insurance provider’s stock worth $329,000 after buying an additional 192 shares during the last quarter. 99.13% of the stock is currently owned by institutional investors and hedge funds.

Humana Inc. (NYSE:HUM) opened at 247.28 on Monday. The company has a market capitalization of $35.74 billion, a PE ratio of 20.34 and a beta of 0.91. Humana Inc. has a 12 month low of $163.50 and a 12 month high of $255.27. The firm’s 50-day moving average is $241.05 and its 200-day moving average is $224.57.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, August 2nd. The insurance provider reported $3.49 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $3.08 by $0.41. The business had revenue of $13.53 billion for the quarter, compared to analysts’ expectations of $13.61 billion. Humana had a return on equity of 15.85% and a net margin of 3.37%. During the same period in the prior year, the firm earned $2.30 EPS. Equities analysts anticipate that Humana Inc. will post $11.55 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Tuesday, August 29th will be issued a dividend of $0.40 per share. The ex-dividend date is Thursday, September 28th. This represents a $1.60 annualized dividend and a dividend yield of 0.65%. Humana’s dividend payout ratio (DPR) is 13.06%.

ILLEGAL ACTIVITY NOTICE: This article was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this article on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this article can be viewed at https://www.thecerbatgem.com/2017/08/21/columbus-circle-investors-acquires-171613-shares-of-humana-inc-hum.html.

A number of equities research analysts have recently issued reports on HUM shares. Zacks Investment Research downgraded shares of Humana from a “buy” rating to a “hold” rating in a report on Monday, April 24th. Cowen and Company reissued an “outperform” rating and issued a $230.00 price target on shares of Humana in a report on Tuesday, April 25th. Evercore ISI reissued an “outperform” rating and issued a $240.00 price target on shares of Humana in a report on Tuesday, April 25th. Cantor Fitzgerald increased their price target on shares of Humana from $190.00 to $200.00 and gave the stock a “neutral” rating in a report on Wednesday, April 26th. Finally, Jefferies Group LLC reissued a “hold” rating and issued a $230.00 price target (up from $221.00) on shares of Humana in a report on Thursday, May 4th. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating and twelve have given a buy rating to the company’s stock. Humana currently has a consensus rating of “Hold” and a consensus target price of $244.35.

In other news, VP Heidi S. Margulis sold 1,500 shares of the company’s stock in a transaction that occurred on Friday, May 26th. The stock was sold at an average price of $231.96, for a total transaction of $347,940.00. Following the sale, the vice president now directly owns 8,150 shares of the company’s stock, valued at approximately $1,890,474. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Brian P. Leclaire sold 4,971 shares of the company’s stock in a transaction that occurred on Wednesday, June 28th. The stock was sold at an average price of $240.00, for a total value of $1,193,040.00. Following the sale, the senior vice president now directly owns 14,258 shares in the company, valued at $3,421,920. The disclosure for this sale can be found here. Insiders have sold a total of 41,406 shares of company stock worth $10,355,086 over the last ninety days. Insiders own 0.80% of the company’s stock.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.